Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9827244
SERIAL NO

15169850

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound having the general formula (V), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
F HOFFMANN-LA ROCHE AGBASEL SUI BASEL BASEL-STADT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buschmann, Helmut Aachen, DE 94 442
Cusack, Stephen Seyssinet-Pariset, FR 33 50
Handler, Norbert Vienna, AT 19 27
Neidhart, Werner Hagenthal-le-Bas, FR 92 714
Roch, Franz-Ferdinand Vienna, AT 5 9
Schulz-Gasch, Tanja Ziefen, CH 48 241
Szolar, Oliver Vienna, AT 21 29
Weikert, Robert Basel, CH 16 20
Wolkerstorfer, Andrea Vienna, AT 21 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 28, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 28, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00